Patents Assigned to Ostara Biomedical Ltd
  • Patent number: 10987406
    Abstract: The present invention relates to methods of and compositions comprising cytokines for, improving the success rate of embryo implantation and the success rate of pregnancy rates in females, by providing an immunopermissive uterine environment prior to insemination or implantation of embryos. The methods of the present invention are used to make the uterus more receptive or less hostile to, for example, transferred embryos, sperm or other allografted tissue.
    Type: Grant
    Filed: March 22, 2019
    Date of Patent: April 27, 2021
    Assignee: Ostara Biomedical Ltd.
    Inventors: Nadia Gopichandran, Nicolas Michel Orsi, David Andrew Brooke
  • Patent number: 10588944
    Abstract: The present invention relates to methods, compositions and kits for controlling, managing or manipulating the non-human mammalian female reproductive cycle. The methods include oestrus induction and/or synchronisation, induction of ovulation and/or superovulation and optionally further includes a method of providing an immunopermissive uterine environment prior to insemination or implantation of embryos.
    Type: Grant
    Filed: October 4, 2016
    Date of Patent: March 17, 2020
    Assignee: Ostara Biomedical Ltd.
    Inventors: Nicolas Michel Orsi, Nadia Gopichandran, David Andrew Brooke
  • Patent number: 10293029
    Abstract: The present invention relates to methods of and compositions comprising cytokines for, improving the success rate of embryo implantation and the success rate of pregnancy rates in females, by providing an immunopermissive uterine environment prior to insemination or implantation of embryos. The methods of the present invention are used to make the uterus more receptive or less hostile to, for example, transferred embryos, sperm or other allografted tissue.
    Type: Grant
    Filed: January 27, 2016
    Date of Patent: May 21, 2019
    Assignee: Ostara Biomedical Ltd.
    Inventors: Nadia Gopichandran, Nicolas Michel Orsi, David Andrew Brooke
  • Patent number: 10159712
    Abstract: The present invention relates to methods of and compositions comprising cytokines for, improving the success rate of embryo implantation and the success rate of pregnancy rates in females, by providing an immunopermissive uterine environment prior to insemination or implantation of embryos. The methods of the present invention are used to make the uterus more receptive or less hostile to, for example, transferred embryos, sperm or other allografted tissue.
    Type: Grant
    Filed: August 12, 2014
    Date of Patent: December 25, 2018
    Assignee: Ostara Biomedical Ltd.
    Inventors: Nadia Gopichandran, Nicolas Michel Orsi, David Andrew Brooke
  • Patent number: D771254
    Type: Grant
    Filed: December 3, 2014
    Date of Patent: November 8, 2016
    Assignee: Ostara Biomedical Ltd
    Inventor: Nadia Gopichandran
  • Patent number: D783817
    Type: Grant
    Filed: September 30, 2016
    Date of Patent: April 11, 2017
    Assignee: Ostara Biomedical Ltd.
    Inventor: Nadia Gopichandran